14th European ISSX Meeting

June, 26-29, Cologne, Germany.

We will be exhibiting and presenting a poster at the 14th European ISSX Meeting in Cologne, Germany 26-29 June. 

Iain Shaw, Director, 14-C Enabled Drug Development will be attending and if you wish to discuss human ADME and 14c radiolabelled study support, we will be located at booth 211.

The 11th International ISSX Meeting will bring together individuals who are actively working on drug/xenobiotic research in diverse fields including basic and clinical pharmacology and therapeutics, toxicology, oncology and genetics. 

With over 30 years’ experience, we have the scientific expertise and operational know-how to design and deliver human ADME programs in preparation for NDA/MAA submissions.

To find out more, contact Iain directly via email: iain.shaw@quotientclinical.com or call +44 750 010 4486